Quarterly report pursuant to Section 13 or 15(d)

STATEMENTS OF OPERATIONS

v3.20.1
STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Operating costs and expenses    
Research and development $ 12,371 $ 5,674
General and administrative 2,625 1,745
Total operating expenses 14,996 7,419
Loss from operations (14,996) (7,419)
Other income    
Dividend and interest income, net 85 215
Net loss $ (14,911) $ (7,204)
Net loss per share attributable to common stockholders basic and diluted $ (0.79) $ (0.46)
Weighted average shares outstanding - basic and diluted 18,968,096 15,663,795